ABSTRACT
Introduction Partial pancreatoduodenectomy (PD) is the treatment of choice for various benign and malignant tumours of the pancreatic head or the periampullary region. For reconstruction of the gastrointestinal passage, two stomach preserving PD variants exist: pylorus preservation (ppPD), or pylorus resection (prPD) with preservation of the stomach. In pancreatic surgery, delayed gastric emptying (DGE) remains a serious complication after PD with an incidence varying between 4.5% and 45%, potentially delaying hospital discharge or further treatment, e.g. adjuvant chemotherapy. Evidence is lacking to assess which variant of PD entails fewer postoperative DGE.
Methods and analysis The protocol of a large-scale, multicentre, pragmatic, two-arm parallel-group, registry-based randomised controlled trial (rRCT) using a two-stage group-sequential design is presented. This patient-blind rRCT aims to demonstrate the superiority of prPD over ppPD with respect to the overall incidence of DGE within 30 days after index surgery in a German real-world setting. A total of 984 adults undergoing elective PD for any indication will be randomised in a 1:1 ratio. Patients will be recruited at about 30 hospitals being members of the StuDoQ|Pancreas registry established by the German Society of General and Visceral Surgery (DGAV). The postoperative follow-up for each patient will be 30 days. The primary analysis will follow an intention-to-treat approach and applies a binary logistic random intercepts model. Secondary perioperative outcomes include overall severe morbidity (Clavien-Dindo-classification), blood loss, 30-day all-cause mortality, postoperative hospital stay, and operation time. Complication rates and adverse events will be closely monitored.
Ethics and dissemination This protocol was approved by the leading ethics committee of the Medical Faculty of the Ludwig-Maximilians-Universität, Munich (reference no. 19-221). The results will be published in a peer-reviewed journal and presented at international conferences. Study findings will also be disseminated via the website (http://www.dgav.de/studoq/pylorespres/).
Trial registration number DRKS-ID: DRKS00018842 (https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00018842, prospectively registered on 24-Oct-2019)
Strengths and limitations of this study
▪ This will be the first large-scale, surgical registry-based randomised controlled trial (rRCT) in Germany.
▪ Patients will be blinded to the allocated and actually performed treatment.
▪ The active control intervention will be pylorus preserving pancreatoduodenectomy (PD), currently the surgical standard treatment of tumours of the pancreatic head and periampullary region.
▪ Synthesizing evidences from RCTs for this comparative effectiveness research question (preserving vs. resecting PD) is inconclusive with respect to delayed gastric emptying (DGE), a common post-operative complication.
▪ The rRCT approach combines the advantages of a prospective (adaptive two-stage) 2-arm parallel-group RCT and the German multicentre StuDoQ|Pancreas registry as platform for patient enrolment, allocation and data collection, with the aim of improving the evidence-based surgical techniques for PD.
Competing Interest Statement
All authors report grants from the German Research Foundation during the conduct of the study. The authors declare that no conflict of interest exist.
Clinical Trial
DRKS ID: DRKS00018842 https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00018842
Funding Statement
This is an investigator-initiated trial funded by the Deutsche Forschungsgemeinschaft/German Research Foundation (DFG). Following a competitive external peer review by the scientific advisory board, this study was awarded a grant in 2019 (DFG reference number: WE 2008/9-0). The funding agency had no role in the development of the study design, and will not have a role in data collection, analysis, interpretation of the results, manuscript development, or the decision to submit the final report for publication. The protocol is based on the project application, which received previous peer review as part of the grant funding process. The Medical Faculty of the Ludwig-Maximilians-University, Munich, Germany, is the sponsor of the trial.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the protocol has been granted from each of the participating medical facilities involved in this trial prior to patient recruitment (leading ethics committee of the Medical Faculty of the Ludwig-Maximilians-University, Munich, Germany; reference no. 19-221). This paper presents the protocol version 3.0, 22.09.2020.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
E-mail addresses of co-authors adrion{at}ibe.med.uni-muenchen.de, bernhard.renz{at}med.uni-muenchen.de, carsten.klinger{at}dgav.de, Matthias.Ilmer{at}med.uni-muenchen.de, Jan.DHaese{at}med.uni-muenchen.de, hbuhr{at}dgav.de, mansmann{at}ibe.med.uni-muenchen.de, jens.werner{at}med.uni-muenchen.de
↵‡ Group authorship for the collaborators of the PyloResPres study group: Collaborators including their affiliations are listed in the Supplementary file 1.
Data Availability
All data of the StuDoQ|Pancreas registry are stored in pseudonymized form, and any re-identification can only be done by the treating, participating hospital. Individual participant data cannot be shared publicly because participants did not explicitly consent to the sharing of their data as per the European Union's General Data Protection Regulation (GDPR) and the corresponding German privacy laws. De-identified participant data and a data dictionary defining each field in the dataset will be made available to researchers upon formal request and receipt of a signed data sharing agreement in accordance with the data sharing policies of the LMU Munich, Germany. Data will be available through the Research Ethics Board of the LMU Munich for researchers who meet the criteria for access to confidential data and after approval of a methodologically sound research proposal. Requests for data access can be directed to ethikkommission{at}med.uni-muenchen.de and the Data Use and Access Committee (DUAC) of the Medical Faculty of the University of Munich (duac{at}med.uni-muenchen.de).
List of Abbreviations
- (S)AE(s)
- (serious) adverse event(s)
- (e)CRF
- (electronic) Case report form
- DGAV
- German Society for General and Visceral Surgery (Deutsche Gesellschaft für Allgemeinund Viszeralchirurgie)
- DGE
- Delayed gastric emptying
- DRKS
- German Clinical Trials Register
- EC
- Ethics committee
- EDC
- Electronic data capture
- FAS
- Full analysis set
- FPF(L)V
- First patient first (last) visit
- GDPR
- General Data Protection Regulation
- ICH-GCP
- International conference for harmonisation (of technical requirements for pharmaceuticals for human use) − good clinical practice guideline
- ICU
- Intensive care unit
- ISGPS
- International Study Group of Pancreatic Surgery
- ITT
- Intention to treat
- LPF(L)V
- Last patient first (last) visit
- PD
- Partial pancreatoduodenectomy
- POD
- Postoperative day
- PP
- per protocol
- ppPD
- Pylorus preservation in pancreatoduodenectomy
- prPD
- Pylorus resection in pancreatoduodenectomy
- QoL
- Quality of life
- REDCap
- Research Electronic Data Capture
- rRCT
- registry-based randomised clinical trial
- SPIRIT
- Standard Protocol Items: Recommendations for Interventional Trials
- StuDoQ
- Study, Documentation and Quality centre (Studien-, Dokumentations-und Qualitätszentrum) of the DGAV
